Financials data is unavailable for this security.
Cash flow in USDView more
In 2024, Nascent Biotech Inc increased its cash reserves by 116.11%, or 199.93k. Cash Flow from Financing totalled 1.39m or -- of revenues. In addition the company used 1.19m for operations while cash used for investing totalled .
Cash flow per share | -0.0117 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.003 |
---|---|
Tangible book value per share | -0.003 |
More ▼
Balance sheet in USDView more
Current ratio | 0.3065 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼